Abstract:Background: Abundant α-synuclein (α-syn) protein accumulation is the pathological hallmark of Parkinson disease (PD) and it induces dopaminergic (DA) neuron apoptosis. This study explored the influence of long non-coding RNA (lncRNA) SNHG14 on α-syn expression and PD pathogenesis.Methods: PD model was established in mouse with a stereotaxic surgery. In the brain tissue of PD mice, the expression levels of SNHG14, miR-133b, α-syn and SP-1 protein were determined. Chromatin immunoprecipitation (ChIP) assay was performed to validate the binding between SP-1 and SNHG14 promoter. DA neuron viability was analyzed with CCk-8 assay. Interplay between SNHG14 and miR-133b was examined with RNA immunoprecipitation (RIP) and RNA pull-down assay. Regulatory relationship between miR-133b and α-syn was verified through dual luciferase reporter assay.Results: Compared with the sham group (n=7), the expression of SNHG14, αsyn and SP-1 protein was increased in PD mice model (n=7), while miR-133b was down-regulated. Binding between transcriptional factor SP-1 and SNHG14 promoter was enhanced by rotenone, and promoted SNHG14 expression. Interference of SNHG14 ameliorated the DA neuron injury induced by rotenone. Interaction between SNHG14 and miR-133b was identified in clonal mesencephalic DA cell line MN9D cells. MiR-133b negatively regulated α-syn expression by targeting its 3'-UTR of mRNA. SNHG14 regulated α-syn expression via targeting miR-133b. Interference of SNHG14 improved DA neuron activity that damaged by rotenone through miR-133b. Interference of SNHG14 mitigated neuron injury in PD mouse model.Conclusion: Interference of lncRNA SNHG14 expression mitigates dopaminergic neuron injury by down-regulating α-syn via targeting miR133b, which contributes to improving PD pathological state.Funding Statement: This study was supported by the grants from the Youth Entrepreneurship Foundation of the First Affiliated Hospital of Zhengzhou University.Declaration of Interests: The authors declare no conflict of interest.Ethics Approval Statement: All animal experiments were approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University.

Downregulation of Lncrna BACE1-AS Improves Dopamine-Dependent Oxidative Stress in Rats with Parkinson’s Disease by Upregulating Microrna-34B-5p and Downregulating BACE1

LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease

Suppression Of Microrna-342-3p Increases Glutamate Transporters And Prevents Dopaminergic Neuron Loss Through Activating The Wnt Signaling Pathway Via P21-Activated Kinase 1 In Mice With Parkinson'S Disease

LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson?s disease by regulating the miR-223-3p/NRP1 axis

Mir-124 Downregulates Bace 1 and Alters Autophagy in App/Ps1 Transgenic Mice

LncRNA-T199678 Mitigates α-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p

The NONRATT023402.2/rno-miR-3065-5p/NGFR Axis Affects Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223–3p/NRP1 axis

Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson’s disease rats via regulation of TLR/NF-κB signaling pathway

Dopaminergic Neuron Injury in Parkinson Disease is Mitigated by Interfering Lncrna SNHG14 Expression to Regulate the Mir-133B/α-synuclein Pathway

LncRNA-T199678 Mitigates -Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p

Bacoside-A Exerts Protective Effect Against Parkinson’s Disease-Induced Functional Damage in Mice Via Inhibition of Apoptosis and Oxidative Response

Long non-coding RNA SNHG1 mediates neuronal damage in Parkinson’s disease model cells by regulating miR-216a-3p/Bcl-2-associated X protein

Retracted: Suppression of Microrna‐342‐3p Increases Glutamate Transporters and Prevents Dopaminergic Neuron Loss Through Activating the Wnt Signaling Pathway Via P21‐activated Kinase 1 in Mice with Parkinson's Disease

Suppression of Abnormal Α-Synuclein Expression by Activation of BDNF Transcription Ameliorates Parkinson's Disease-Like Pathology.

LncRNA BDNF-AS as ceRNA regulates the miR-9-5p/BACE1 pathway affecting neurotoxicity in Alzheimer's disease

lncRNA PART1 mitigates MPP+-induced neuronal injury in SH-SY5Y cells via micRNA-106b-5p/MCL1 axis

The Long Non-Coding RNA BDNF-AS Induces Neuronal Cell Apoptosis by Targeting Mir-125B-5p in Alzheimer's Disease Models.

Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson's disease through regulating microRNA-221-3p/ transforming growth factor /nuclear factor E2-related factor 2 axis

Knockdown of Long Non-Coding RNA AL049437 Mitigates MPP+ -Induced Neuronal Injury in SH-SY5Y Cells Via the Microrna-205-5p/mapk1 Axis.

LINC00667 Regulates MPP+‐induced Neuronal Injury in Parkinson’s Disease